Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) major shareholder J.H. Whitney Equity Partners V sold 750,000 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $5.20, for a total transaction of $3,900,000.00. Following the sale, the insider now owns 28,890,756 shares of the company's stock, valued at $150,231,931.20. This represents a 2.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.
J.H. Whitney Equity Partners V also recently made the following trade(s):
- On Monday, May 19th, J.H. Whitney Equity Partners V sold 1,560,700 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.36, for a total value of $8,365,352.00.
- On Monday, May 12th, J.H. Whitney Equity Partners V sold 47,039 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.72, for a total transaction of $269,063.08.
- On Tuesday, April 1st, J.H. Whitney Equity Partners V sold 5,580 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.63, for a total transaction of $31,415.40.
- On Monday, March 24th, J.H. Whitney Equity Partners V sold 268 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.63, for a total transaction of $1,508.84.
- On Tuesday, March 18th, J.H. Whitney Equity Partners V sold 61,564 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.51, for a total transaction of $339,217.64.
Aveanna Healthcare Stock Down 3.1%
AVAH stock traded down $0.16 during midday trading on Friday, hitting $4.93. The company's stock had a trading volume of 65,595 shares, compared to its average volume of 323,940. The firm has a 50-day simple moving average of $5.09 and a 200-day simple moving average of $4.92. The firm has a market capitalization of $960.84 million, a P/E ratio of -14.48 and a beta of 2.03. Aveanna Healthcare Holdings Inc. has a 52-week low of $2.32 and a 52-week high of $6.19.
Analysts Set New Price Targets
A number of analysts have issued reports on AVAH shares. UBS Group boosted their target price on Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research report on Friday, May 9th. Truist Financial cut their price objective on Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a report on Friday, April 11th.
Check Out Our Latest Research Report on Aveanna Healthcare
Institutional Investors Weigh In On Aveanna Healthcare
Hedge funds have recently bought and sold shares of the stock. Price T Rowe Associates Inc. MD grew its position in shares of Aveanna Healthcare by 5.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 53,699 shares of the company's stock worth $246,000 after buying an additional 2,649 shares in the last quarter. Rhumbline Advisers lifted its stake in Aveanna Healthcare by 4.0% in the first quarter. Rhumbline Advisers now owns 75,581 shares of the company's stock worth $410,000 after acquiring an additional 2,918 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Aveanna Healthcare by 0.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company's stock worth $2,133,000 after acquiring an additional 4,047 shares in the last quarter. MetLife Investment Management LLC increased its position in shares of Aveanna Healthcare by 16.2% in the 1st quarter. MetLife Investment Management LLC now owns 31,251 shares of the company's stock valued at $169,000 after purchasing an additional 4,349 shares during the last quarter. Finally, AQR Capital Management LLC raised its holdings in shares of Aveanna Healthcare by 21.2% in the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company's stock valued at $142,000 after purchasing an additional 4,602 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.
About Aveanna Healthcare
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Further Reading

Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.